With more than 1.6 million new cases of cancer occurring each year, anticancer medications are in high demand. Escalating prescription drug prices have become a significant concern. Anticancer medications are among the most expensive prescription medications, many of them exceeding $100 000 a year. The survival benefits of certain newer anticancer medications may be a few months more than that from the existing treatment but at a much higher price tag. Drug cost may play a substantial role in making treatment choices. Multiple factors leading to high prices and some potential solutions to lower them have been highlighted.
GoldmanDPJoyceGFZhengY.Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007;298:61-69.
TefferiAKantarjianHRajkumarS. In support of a patient-driven initiative and petition to lower the high price of cancer drugs. Mayo Clin Proc. 2015;90:996-1000. doi:10.1016/j.mayocp.2015.06.001.
SiddiquiMRajkumarS.The high cost of cancer drugs and what we can do about it. Mayo Clin Proc. 2012;87:935-943. doi:10.1016/j.mayocp.2012.07.007.
12.
Pharmaceutical Research and Manufacturers of America. 2015 Biopharmaceutical Research Industry Profile. Washington, DC: PhRMA; 2015.
13.
DimasiJAGrabowskiHGHansenRW.Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ. 2016;47:20-33. Accessed December 14, 2016.
ZafarSPeppercornJSchragD. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist. 2013;18:381-390. doi:10.1634/theoncologist.2012-0279.
23.
KellyRJFordePMElnahalSMForastiereAARosnerGLSmithTJ.Patients and physicians can discuss costs of cancer treatment in the clinic. J Oncol Pract. 2015;11:308-312. doi:10.1200/jop.2015.003780.
